Market map: Meet the companies deploying AI agents in the outpatient setting
First, a disclaimer: No market map is fully exhaustive.
We focused our efforts on the companies deploying AI agents in the ambulatory or outpatient setting. These companies are generally also post-series A, as there has been an explosion of pre-seed and seed activity in the space. We also excluded vendors whose primary business model is selling into healthcare systems. Submissions came from a cross section of our network, inclusive of venture capital investors, operators, and founders (see the full list that contributed directly underneath the map).
To be fully transparent, we struggled a bit in the scribe category because, in some cases, the agents involve a roadmapping exercise, while others are live.
If your company fits the criteria and should be on the list, reach out to us before our next update!
|
Reserve Your Spot for Upcoming Webinars!
Webinar Topic | Panelists’ | Timing | Registration |
|---|---|---|---|
Privacy AI and the future of HIPAA with the former founding director of ONC | Jodi Daniel, Christina Farr | June 3rd, 2026 | |
Not everyone can access the Top 1% of physicians. Will AI change that? | Daniel Stein | June 23rd, 2026 |
Want to support Second Opinion?
- 🌟 Leave a review for the Second Opinion Podcast
- 📧 Share this email with other friends in the healthcare space!
- 💵 Become a paid subscriber!
- 📢 Become a sponsor
About the author
Christina Farr
Christina Farr is a healthcare writer and investor. Formerly at CNBC and Reuters, she covers digital health, startups, and policy, blending reporting with analysis and investing perspective to help leaders navigate healthcare’s evolving landscape.
New York City